Sfoglia per Rivista
Liver fibrosis in adult thalassemia patients assessed by transient elastography
2008 E. Cassinerio, M. Fraquelli, M. Fasulo, C. Cesaretti, P. Pattoneri, C. Rigamonti, D. Conte, M.D. Cappellini
Liver iron concentration and morbidity in patients with thalassemia intermedia
2011 K. Musallam, J. Wood, M.D. Cappellini, I. Motta, H. Tamim, A. Taher
Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma
2019 E. Taiana, D. Ronchetti, V. Favasuli, K. Todoerti, M. Manzoni, N. Amodio, P. Tassone, L. Agnelli, A. Neri
Long-term molecular remission after conventional chemotherapy in a patient with Philadelphia-negative acute lymphoblastic leukemia
1996 M. Ladetto, P. Corradini, M. Astolfi, S. Campana, C. Tarella, A. Pileri
Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second-and third-generation tyrosine kinase inhibitors
2019 G. Caocci, O. Mulas, M. Annunziata, L. Luciano, E. Abruzzese, M. Bonifacio, E.M. Orlandi, F. Albano, S. Galimberti, A. Iurlo, P. Pregno, N. Sgherza, B. Martino, G. Binotto, F. Castagnetti, A. Gozzini, M. Bocchia, C. Fozza, F. Stagno, M.P. Simula, F. De Gregorio, M. Trawinska, L. Scaffidi, C. Elena, I. Attolico, C. Baratè, D. Cattaneo, F. Pirillo, G. Gugliotta, A. Sicuranza, M. Molica, G. La Nasa, R. Foà, M. Breccia
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
2020 S. Riva, I. Mancini, A. Maino, B. Ferrari, A. Artoni, P. Agosti, F. Peyvandi
The long-term outcome of high-risk follicular lymphoma patients receiving intensive therapy with autograft as primary treatment : results from three consecutive prospective trials performed in Italy over the past 18 years
2009 C. Tarella, M. Ladetto, M. Ruella, R. Passera, A. Pileri, A.M. Gianni, P. Corradini
Long-term outcome of ric-allo SCT for myeloma
2007 V. Montefusco, F. Ciceri, J. Peccatori, L. Farina, A. Oliveri, K. Aprile Hoenstaufen, G. Lambertenghi Deliliers, A.M. Gianni, M. Bregni, P. Corradini
Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis
2006 V. Perfetti, S. Siena, G. Palladini, M. Bregni, M. Di Nicola, L. Obici, M. Magni, L. Brunetti, A.M. Gianni, G. Merlini
Low dose alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia
2011 G. Gritti, G. Reda, F. Maura, A. Piciocchi, L. Baldini, S. Molica, A. Neri, A. Cortelezzi
Low dose campath 1-H is highly effective and safe in advanced chronic CLL
2006 A. Cortelezzi, M.C. Pasquini, U. Gianelli, B. Sarina, C. Vener, G. Reda, F. Ripamonti, L. Nobili, G. Lambertenghi Deliliers
Low dose dasatinib in refractory imatinib mesylate chronic myeloid leukemia : case report
2007 F. Radaelli, G. Reda, F. Ripamonti, A. Gardellini, C. Vener, G. Lambertenghi Deliliers
Low risk IgG Monoclonal Gammopathy of undetermined significance (MGUS) : proposal and validation of a prognostic scoring system
2007 F.G. Rossi, L. Marcheselli, D. Rossi, V. Callea, A. Guffanti, V. Federico, M. De Muro, A. Baraldi, P. Musto, A. Bacigalupo, G. Gaidano, M.T. Petrucci, M. Goldaniga, L. De Paoli, L. Baldini
Low vitamin B6 levels and the risk of recurrent venous thromboembolism
2007 G. Hron, R. Lombardi, S. Eichinger, A. Lecchi, P.A. Kyrle, M. Cattaneo
Low-dose ALEMTUZUMAB monotherapy in advanced chronic lymphocytic leukemia
2006 A. Cortelezzi, M.C. Pasquini, G. Reda, F. Ripamonti, B. Sarina, W. Barcellini, G. Lambertenghi Deliliers
LOW-DOSE CYTOSINE-ARABINOSIDE (ARA-C) THERAPY IN THE MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOGENOUS LEUKEMIA
1987 A. MAIOLO, P. FOA, M. CORTELLARO, G. LAMBERTENGHIDELILIERS, A. COLANTONI, B. CESANA, G. CASTOLDI, M. CAZZOLA, M. GIORDANO, A. RICCARDI, E. POLLI
Low-dose subcutaneous alemtuzumab therapy for patients with refractory chronic lymphoblastic leukaemia (B-CLL)
2005 A. Cortelezzi, M.C. Pasquini, N.N. Fantini, V.R. Zilioli, M. Colombi, B. Sarina, F. Somalvico, G. LAMBERTENGHI DELILIERS
Low-dose subcutaneous campath (CAM) is highly effective and safe in advanced and chemotherapy-refractory B-CLL : results of a prospectic and multicenter phase II study
2007 A. Cortelezzi, M.C. Pasquini, W. Barcellini, P. Musto, U. Gianelli, G. Reda, G. Lambertenghi Deliliers
Lymphoproliferative disease and acquired C1 inhibitor deficiency
2007 R. Castelli, D.M. Lambertenghi Deliliers, L.C. Zingale, E.M. Pogliani, M. Cicardi
Lymphoproliferative Disease In Primary B-cell Immunodeficiency : Lymphoplasmocytoid Lymphoma Or Sjogrens Pseudo-lymphoma
1986 C. Montecucco, E.L. Cherieligniere, R. Rosso, A. Riccardi, R. Carnevale, R. Caporali, M. Gorini
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile